Tuesday, December 2, 2008

Teva Introduces Rocuronium Bromide Injection

Dec, 1, 2008 – Teva Health Systems is pleased to announce the introduction and availability of Rocuronium Bromide Injection. This product is AP rated to Zemuron®* Injection. Rocuronium Bromide Injection is available in 10 mg/mL-50 mg and 10 mg/mL-100 mg, in multiple dose glass vials.

The details can be read here.

No comments: